Publication Name	World Journal of Gastroenterology
Manuscript ID	93756
Country	Taiwan

Received	2024-03-05 02:54
Peer-Review Started	2024-03-05 02:54
To Make the First Decision
Return for Revision	2024-04-25 07:54
Revised	2024-04-26 00:34
Second Decision	2024-05-11 02:37
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-05-11 06:30
Articles in Press	2024-05-11 06:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-23 02:23
Publish the Manuscript Online	2024-06-03 08:49

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Navigating the complex terrain of hepatitis B virus reactivation in the era of Bruton tyrosine kinase inhibitors
Manuscript Source	Invited Manuscript
All Author List	Wei-Nung Liu, Ming-Shen Dai, Felicia Lin and Gen-Min Lin
ORCID	Author(s) ORCID Number Felicia Lin http://orcid.org/0000-0002-3092-0831 Gen-Min Lin http://orcid.org/0000-0002-5509-1056
Funding Agency and Grant Number
Corresponding Author	Gen-Min Lin, FACC, FAHA, FESC, MD, PhD, Academic Editor, Academic Fellow, Chief Physician, Department of Medicine, Hualien Armed Forces General Hospital, No. 100 Jinfeng Street, Hualien City 970, Taiwan. farmer507@yahoo.com.tw
Key Words	Hepatitis B virus reactivation; Bruton tyrosine kinase inhibitors; Hematologic malignancies; Solid tumors; Prophylaxis guidelines
Core Tip	This is an invited editorial for the coming paper “Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis”.
Publish Date	2024-06-03 08:49
Citation	<p>Liu WN, Dai MS, Lin F, Lin GM. Navigating the complex terrain of hepatitis B virus reactivation in the era of Bruton tyrosine kinase inhibitors. <i>World J Gastroenterol</i> 2024; 30(21): 2748-2750</p>
URL	https://www.wjgnet.com/1007-9327/full/v30/i21/2748.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i21.2748

Full Article (PDF)	WJG-30-2748-with-cover.pdf
Manuscript File	93756_Auto_Edited-YJP.docx
Answering Reviewers	93756-answering-reviewers.pdf
Audio Core Tip	93756-audio.mp3
Conflict-of-Interest Disclosure Form	93756-conflict-of-interest-statement.pdf
Copyright License Agreement	93756-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	93756-non-native-speakers.pdf
Peer-review Report	93756-peer-reviews.pdf
Scientific Misconduct Check	93756-Bing-Chen YL-2.png
Scientific Editor Work List	93756-scientific-editor-work-list.pdf
CrossCheck Report	93756-scientific-misconduct-check.pdf